Jeffrey Modell Foundation Launches GENIE Educational Grant
The G.E.N.I.E. grant funds educational programs with a focus on PI to foster global collaboration, encourage meaningful dialogue, and promote ongoing education about PI to improve the quality of life of patients worldwide. Grant recipients will share their research findings, patient success stories, treatment methodologies, and more, with members of the Jeffrey Modell Centers Network (JMCN) across the globe. This exchange is expected to advance the field, educate peers, and inspire ongoing collaboration.
Dr.
Co-founder
"From the very beginning, the Foundation has been committed to advancing the understanding of PI. There was a clear need for a new program that would further enhance physician education, and GENIE will take developments in the field to the next level," said Co-Founder
Awards will be granted on a rolling basis throughout the year following review and approval by the grant committee.
For more information about the G.E.N.I.E. grant and application details, please visit www.info4pi.org.
About the Jeffrey Modell Foundation
Vicki and Fred Modell established the Jeffrey Modell Foundation (JMF) in 1987, in memory of their son Jeffrey, who passed away at the age of fifteen, from complications of Primary Immunodeficiency, a genetic condition that is chronic, serious, and often fatal if not diagnosed correctly.
JMF is a global non-profit organization dedicated to early diagnosis, meaningful treatments and, ultimately, cures through research, physician education, public awareness, advocacy, patient support, newborn screening, and genetic sequencing. For more information visit https://info4pi.org/ or watch Do Something: The Jeffrey Modell Story online, available in seven languages.
Media Contact:
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/jeffrey-modell-foundation-launches-genie-educational-grant-302218422.html
SOURCE Jeffrey Modell Foundation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ASSA ABLOY: Quarterly Report Q2 2026
- From the World Cup Stadium to 24/7 Support: How HTX is Redefining VIP Services
- Camurus' NDA resubmission for CAM2029 in acromegaly accepted for review by the US FDA
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share